Response: Comments on The renin-angiotensin system and the development of new antiglaucoma medications

About

• Brief History
• Open Science Compliance
• Publication Ethics
• Focus and Scope
• Digital Preservation
• Editorial Policy
• Ethics Committee
• Copyright License

Issues

• Current Issue
• Previous
• Supplements
• Eye Images
• Commented Papers
• Advanced Search

Editorial Board

• Meet the Team

Submission

• Instructions to Authors
• Submission of articles
• Required Documents
• Editorial Responsibilities
• Charges Fees
• Conflict of interest

Media

• Videos
• Podcasts

Contact

• Contact